SCHEMBL6444289

SCHEMBL6444289

Oc1ccc(-c2nc(-c3ccc(O)cc3)nc(-c3ccc(O)cc3O)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
NTSR1 P30989 1/20 0.50
NPC1 O15118 3/20 0.48
RAB9A P51151 2/20 0.48
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
USP2 O75604 1/20 0.48
TP53 P04637 1/20 0.48
PKM P14618 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
ALOX5 P09917 1/20 0.47
ADORA3 P0DMS8 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA2B P29275 1/20 0.44
ADORA1 P30542 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4981440 1.00 MEN1 (0.50) MEN1KMT2ANTSR1NPC1RAB9A
SCHEMBL29625130 0.89 NPC1 (0.52) NPC1RAB9AMAPTALOX5ESR2
SCHEMBL547889 0.89 NPC1 (0.52) NPC1RAB9AMAPTALOX5ESR2
SCHEMBL29381883 0.89 MEN1 (0.53) MEN1KMT2ANTSR1NPC1RAB9A
SCHEMBL8036067 0.89 MEN1 (0.53) MEN1KMT2ANTSR1NPC1RAB9A
SCHEMBL580776 0.89 MEN1 (0.53) MEN1KMT2ANTSR1NPC1RAB9A
SCHEMBL1243182 0.89 MEN1 (0.53) MEN1KMT2ANTSR1NPC1RAB9A
SCHEMBL14070528 0.89 MEN1 (0.47) MEN1KMT2ANTSR1NPC1RAB9A
SCHEMBL1245329 0.89 MEN1 (0.47) MEN1KMT2ANTSR1NPC1RAB9A
SCHEMBL29740228 0.89 ALOX5 (0.60) MEN1KMT2ANTSR1MAPTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6864325-B2 Metathesis ring-opening polymerization; rigidity, flexible packaging; photostability, heat and oxidation resistance CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-03-08 US claimed
US-20030191242-A1 Romp with oligomeric uv-absorbers CIBA SPECIALTY CHEMICALS CORP. 2003-10-09 US claimed
US-6864325-B2 Metathesis ring-opening polymerization; rigidity, flexible packaging; photostability, heat and oxidation resistance CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-03-08 US disclosed
US-20030191242-A1 Romp with oligomeric uv-absorbers CIBA SPECIALTY CHEMICALS CORP. 2003-10-09 US disclosed
EP-1263833-A1 ROMP WITH OLIGOMERIC UV-ABSORBERS Ciba SC Holding AG (CH) 2002-12-11 EP disclosed
WO-2001062821-A1 ROMP WITH OLIGOMERIC UV-ABSORBERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191242-A1 Romp with oligomeric uv-absorbers OSTC, OCIAD1, OCIAD2 MEN1 1090/4885KMT2A 4216/4885NTSR1 3307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.